Kyverna Therapeutics (KYTX) Treasury Shares (2023)

Kyverna Therapeutics (KYTX) has 4 years of Treasury Shares data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Treasury Shares rose 169.18% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 169.18% YoY) and the FY2025 annual result came in at $1.2 million, up 115.37% from the prior year.
• Treasury Shares rose to $1.7 million in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $114.6 million in Q3 2023 to a low of $544851.0 in Q3 2024.
• A 4-year average of $37.7 million and a median of $1.3 million in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2024 — Treasury Shares slumped 99.52% — and 2026, when it surged 169.18%.
• Tracing KYTX's Treasury Shares over 4 years: stood at $114.6 million in 2023, then plunged by 99.52% to $549001.0 in 2024, then soared by 115.37% to $1.2 million in 2025, then jumped by 44.6% to $1.7 million in 2026.
• The last three Treasury Shares figures came in at $1.7 million (Q1 2026), $1.2 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.